News
Deficiency: If you have a vitamin B12 deficiency you will feel tired or weak, pale skin, loss of appetite, infertility and others. It can also cause balance issue, depression and poor memory.
Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS patients on Ocrevus.
As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential ...
Updated clinical data in heavily pre-treated, CAR-T naïve patients with B-NHL shows prolonged duration of response, with ...
Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Greetings, and welcome to TG Therapeutics First Quarter Conference ...
TG Therapeutics posts Q1 profit and nearly doubles revenue, driven by rising Briumvi sales and higher full-year guidance for 2025.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent ...
BRIUMVI U.S. net revenue of $119.7 million. Raises full year 2025 global net revenue target to approximately $575 million and raises full year BRIUMVI U.S. net ...
The results indicate a prolonged duration of response, significant B-cell depletion, and a well-tolerated safety profile when AlloNK is combined with rituximab. Additionally, the company will ...
With CB-010, Caribou is enrolling patients in a Phase 1 trial in second-line large B cell lymphoma. By the time it reports results, the majority of study participants will have completed at least six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results